DOCSLIB.ORG

Myotubularin Lipid Phosphatase Binds the Hvps15/ Hvps34 Lipid Kinase Complex on Endosomes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Myotubularin Lipid Phosphatase Binds the Hvps15/ Hvps34 Lipid Kinase Complex on Endosomes # 2007 The Authors Journal compilation # 2007 Blackwell Publishing Ltd Traffic 2007; 8: 1052–1067 Blackwell Munksgaard doi: 10.1111/j.1600-0854.2007.00586.x Myotubularin Lipid Phosphatase Binds the hVPS15/ hVPS34 Lipid Kinase Complex on Endosomes Canhong Cao1, Jocelyn Laporte2,3,4,5,6, Received 14 July 2006, revised and accepted for publica- Jonathan M. Backer7, Angela Wandinger- tion 20 April 2007, uncorrected manuscript published online 24 April 2007 Ness1,* and Mary-Pat Stein8 1Molecular Trafficking Laboratory, Department of Myotubularins define a diverse family of lipid phospha- Pathology, University of New Mexico School of tases that when mutated result in severe human diseases Medicine, Albuquerque, NM 87131, USA 2 affecting different tissues such as muscle in X-linked Department of Molecular Pathology, IGBMC (Institut de myotubular myopathy (MTM1)(1,2) and the peripheral Ge´ ne´ tique et de Biologie Mole´ culaire et Cellulaire), Illkirch F-67400, France nervous system in Charcot-Marie-Tooth diseases type 3Inserm, U596, Illkirch F-67400, France 4B1(3) and type 4B2 (2,4). The MTM family consists of 4CNRS, UMR7104, Illkirch F-67400, France 14 highly conserved dual-specificity protein tyrosine phos- 5Universite´ Louis Pasteur, Strasbourg F-67000, France phatase (PTP)-like enzymes: eight are catalytically active 6 Colle` ge de France, Chaire de Ge´ ne´ tique Humaine, and six contain mutations in their HCX5R PTP catalytic Illkirch F-67400, France motif, rendering them phosphatase dead (5,6). Although 7 Department of Molecular Pharmacology, Albert Einstein homologues do not compensate for individual family College of Medicine, Bronx, NY 10461, USA members, cooperation between catalytically active and 8Department of Biology, California State University Northridge, Northridge, CA 91330, USA inactive myotubularins has been suggested to occur *Corresponding author: Angela Wandinger-Ness, (2,7–9). In addition to a PTP domain, each family member [email protected] has a Suvar 3-9, Enhancer of zeste, Trithorax-interacting domain (10). Most members also have a coiled-coil domain that mediates homodimerization and/or heterodimerization (11,12), and one or more phosphoinositide-binding do- Myotubularins constitute a ubiquitous family of phos- mains that facilitate myotubularin membrane localization phatidylinositol (PI) 3-phosphatases implicated in several neuromuscular disorders. Myotubularin [myotubular (11,13). The human myotubularin family appears to be myopathy 1 (MTM1)] PI 3-phosphatase is shown associ- expressed in all tissues with the exception of hMTMR7, ated with early and late endosomes. Loss of endosomal which is only expressed in brain (14). Thus, differential phosphatidylinositol 3-phosphate [PI(3)P] upon overex- expression levels, intracellular localization or activation of pression of wild-type MTM1, but not a phosphatase-dead distinct myotubularin enzymes may account for different MTM1C375S mutant, resulted in altered early and late disease states observed when closely related myotubularin endosomal PI(3)P levels and rapid depletion of early family members are mutated. Understanding how mutant endosome antigen-1. Membrane-bound MTM1 was myotubularins cause disease necessitates a more detailed directly complexed to the hVPS15/hVPS34 [vacuolar pro- tein sorting (VPS)] PI 3-kinase complex with binding understanding of their cellular localizations, functions and mediated by the WD40 domain of the hVPS15 (p150) interacting partners. adapter protein and independent of a GRAM-domain point mutation that blocks PI(3,5)P2 binding. The WD40 Although first described as dual-specificity PTP enzymes, domain of hVPS15 also constitutes the binding site for the primary substrates for myotubularins in yeast and Rab7 and, as shown previously, contributes to Rab5 mammalian cells are the phosphoinositides PI(3)P (15,16) binding. In vivo, the hVPS15/hVPS34 PI 3-kinase complex and PI(3,5)P (17–19). These phosphoinositide species are forms mutually exclusive complexes with the Rab 2 localized to early and late endosomes and play important GTPases (Rab5 or Rab7) or with MTM1, suggesting a competitive binding mechanism. Thus, the Rab roles in membrane trafficking (20,21). In particular, PI(3)P is GTPases together with MTM1 likely serve as molecular required for the recruitment of factors containing Fab1, switches for controlling the sequential synthesis and YOTB/ZK632.12, Vac1 and early endosome antigen-1 degradation of endosomal PI(3)P. Normal levels of endo- (EEA1) FYVE or phox (PX) domains (22–25). These factors somal PI(3)P and PI(3,5)P2 are crucial for both endosomal include tethering factors (EEA1), phosphoinositide kinases morphology and function, suggesting that disruption of (PIKfyve/Fab1p) and intralumenal vesicle forming machin- endosomal sorting and trafficking in skeletal muscle ery (hepatocyte growth factor-regulated tyrosine kinase when MTM1 is mutated may be a key factor in pre- substrate, Hrs/Vps27p) recruited to early and late endo- cipitating X-linked MTM. somes (26,27). The binding of FYVE/PX domain proteins Key words: Charcot-Marie-Tooth neuropathy, endocyto- to PI(3)P-containing endosomes provides a platform for sis, phosphatidylinositol 3-phosphatase or 3-kinase, Rab the recruitment and assembly of multiprotein complexes GTPase, X-linked myotubular myopathy that promote endosomal tethering, docking, fusion and 1052 www.traffic.dk MTM1 Binds hVPS15/hVPS34 PI 3-Kinase membrane remodeling, thereby facilitating endocytic hVPS34 complex. In addition, we demonstrate that both transport and receptor sorting. This has been demon- Rab7 and MTM1 bind to hVPS15 (formerly called p150), strated most clearly by numerous studies on the sorting the hVPS34 adapter molecule (42) that regulates hVPS34 and degradation of epidermal growth factor receptor activity through its interactions with Rab5 (38) and Rab7 (EGFR), which is highly dependent on PI(3)P and (32,41). The WD40 domain of hVPS15 mediates binding to PI(3,5)P2 (13,28,29). Increased degradation of PI(3)P and Rab5, Rab7 and MTM1. Consequently, binding of the PI(3,5)P2 by overexpression of MTM1 has been shown to hVPS15/hVPS34 complex to the Rab GTPases and cause aberrant endosomal sorting and result in a profound MTM1 is mutually exclusive. The data suggest that tight inhibition of epidermal growth factor (EGF)-stimulated regulation and rapid turnover of the phosphoinositide- receptor degradation (13). Thus, myotubularins play an mediated signals may be accomplished through the cou- important role in integrating cellular phosphoinositide pling of proteins involved in the synthesis and turnover of regulation, membrane trafficking and growth control. PI(3)P on endosomes. In mammalian cells, early and late endosomal PI(3)P are generated by the PI 3-kinase hVPS34 [vacuolar protein Results sorting (VPS)] (30–33), and the PI(3)P 5-kinase PIKfyve generates PI(3,5)P2 from PI(3)P on late endosomes (34). MTM1 is recruited to Rab5- and Rab7-positive early These phosphoinositide species are thought to be short and late endosomes lived because of rapid modification by kinases, dephos- Overexpressed MTM1 has been observed at the plasma phorylation by phosphatases such as the myotubularins or membrane and diffusely dispersed in the cytosol (15,16) degradation by lipases. In yeast, genetic studies demon- and has been shown to diminish early endosomal PI(3)P strate that PI(3)P is transported to vacuoles (the mamma- (43). Recently, however, EGF-dependent recruitment of lian equivalent of lysosomes), where it is either converted overexpressed MTM1 to kinetically defined late endo- into PI(3,5)P2 by Fab1p (35) or degraded by vacuolar somes has been reported (13). As a first step toward hydrolases (36). In mammalian cells, conversion of PI(3)P assessing the endosomal localization and recruitment of to PI(3,5)P2 by PIKfyve on late endosomes is thought to MTM1 more precisely, endogenous and overexpressed trigger the inward invagination of intraluminal vesicles into MTM1 and a phosphatase-dead mutant of MTM1 multivesicular bodies (MVB) and to facilitate sequestration (MTM1C375S) were localized relative to specific early of cargo such as EGFR into MVB (13,37). Hence, balanced and late endosomal markers. synthesis and consumption of PI(3)P and PI(3,5)P2 species on endosomal compartments ensures proper and efficient The endosomal distribution of endogenous MTM1 was endocytic transport. evaluated relative to markers of early and late endosomes (Figure 1A). To reveal the membrane-bound pool of The recruitment and activity of the hVPS34 PI 3-kinase on MTM1, cells were saponin extracted, a method well early and late endosomes depends on the upstream ac- known to preserve membrane ultrastructure while extract- tivation of the small GTPases Rab5 and Rab7, respectively ing cytosolic content (44,45). Endogenous MTM1 was (32,38). Through their organelle-specific localization and consistently observed outlining early endosomal mem- tightly regulated nucleotide binding and hydrolysis cycle, branes that were positive for Rab5. The Pearson’s corre- Rab GTPases are ideally poised as pivotal regulators of lation coefficient (range À1toþ1) for MTM1 and Rab5 was vesicular trafficking (reviewed in 64). Thus, a delicate 0.8 Æ 0.03, indicating a high degree of colocalization. The balance between Rab GTPases, lipid kinases and lipid incomplete overlap between EEA1 and MTM1 may reflect phosphatases must exist to regulate endosomal transport. localization of EEA1 to discrete early endosomal mem- Indirect evidence exists for the
Load more

Recommended publications
  • Genes Retina/RPE Choroid Sclera
    Supplementary Materials: Genes Retina/RPE Choroid Sclera Fold Change p-value Fold Change p-value Fold Change p-value PPFIA2 NS NS 2.35 1.3X10-3 1.5 1.6X10-3 PTPRF 1.24 2.65X10-5 6.42 7X10-4 1.11 1X10-4 1.19 2.65X10-5 NS NS 1.11 3.3X10-3 PTPRR 1.44 2.65X10-5 3.04 4.7X10-3 NS NS Supplementary Table S1. Genes Differentially Expressed Related to Candidate Genes from Association. Genes selected for follow up validation by real time quantitative PCR. Multiple values for each gene indicate multiple probes within the same gene. NS indicates the fold change was not statistically significant. Gene/SNP Assay ID rs4764971 C__30866249_10 rs7134216 C__30023434_10 rs17306116 C__33218892_10 rs3803036 C__25749934_20 rs824311 C___8342112_10 PPFIA2 Hs00170308_m1 PTPRF Hs00160858_m1 PTPRR Hs00373136_m1 18S Hs03003631_g1 GAPDH Hs02758991_g1 Supplementary Table S2. Taqman® Genotyping and Gene Expression Assay Identification Numbers. SNP Chimp Orangutan Rhesus Marmoset Mouse Rat Cow Pig Guinea Pig Dog Elephant Opossum Chicken rs3803036 X X X X X X X X X X X X X rs1520562 X X X X X X rs1358228 X X X X X X X X X X X rs17306116 X X X X X X rs790436 X X X X X X X rs1558726 X X X X X X X X rs741525 X X X X X X X X rs7134216 X X X X X X rs4764971 X X X X X X X Supplementary Table S3. Conservation of Top SNPs from Association. X indicates SNP is conserved.
    [Show full text]
  • Datasheet Blank Template
    SAN TA C RUZ BI OTEC HNOL OG Y, INC . MTMR3 (N-20): sc-47187 BACKGROUND RECOMMENDED SECONDARY REAGENTS Myotubularin and the myotubularin-related proteins (MTMR1-9) belong to a To ensure optimal results, the following support (secondary) reagents are highly conserved family of eukaryotic phosphatases. They are protein tyrosine recommended: 1) Western Blotting: use donkey anti-goat IgG-HRP: sc-2020 phosphatases that utilize inositol phospholipids, rather than phosphoproteins, (dilution range: 1:2000-1:100,000) or Cruz Marker™ compatible donkey as substrates. MTMR family members hydrolyze both Phosphatidylinositol anti- goat IgG-HRP: sc-2033 (dilution range: 1:2000-1:5000), Cruz Marker™ 3-phosphate (PtdIns3P) and PtdIns P2. MTMR2 interacts with MTMR5, an Molecular Weight Standards: sc-2035, TBS Blotto A Blocking Reagent: inactive family member that increases the enzymatic activity of MTMR2 and sc-2333 and Western Blotting Luminol Reagent: sc-2048. 2) Immunoprecip- dictates its subcellular localization. Mutations in MTMR2 cause autosomal itation: use Protein A/G PLUS-Agarose: sc-2003 (0.5 ml agarose/2.0 ml). recessive Charcot-Marie-Tooth type 4B1 (CMT4B1), which is characterized 3) Immunofluorescence: use donkey anti-goat IgG-FITC: sc-2024 (dilution by reduced nerve conduction velocities, focally folded myelin sheaths and range: 1:100-1:400) or donkey anti-goat IgG-TR: sc-2783 (dilution range: demyelination. MTMR3 and MTMR4 can either interact with each other or self 1:100-1:400) with UltraCruz™ Mounting Medium: sc-24941. associate. MTMR6 regulates the activity of the calcium-activated potassium channel 3.1. MTMR9 regulates the activity of MTMR7 and MTMR8.
    [Show full text]
  • Molecular and Genetic Medicine
    Bertazzi et al., J Mol Genet Med 2015, 8:2 Molecular and Genetic Medicine http://dx.doi.org/10.4172/1747-0862.1000116 Review Article Open Access Myotubularin MTM1 Involved in Centronuclear Myopathy and its Roles in Human and Yeast Cells Dimitri L. Bertazzi#, Johan-Owen De Craene# and Sylvie Friant* Department of Molecular and Cellular Genetics, UMR7156, Université de Strasbourg and CNRS, France #Authors contributed equally to this work. *Corresponding author: Friant S, Department of Molecular and Cellular Genetics, UMR7156, Université de Strasbourg and CNRS, 67084 Strasbourg, France, E-mail: [email protected] Received date: April 17, 2014; Accepted date: July 21, 2014; Published date: July 28, 2014 Copyright: © 2014 Bertazzi DL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Mutations in the MTM1 gene, encoding the phosphoinositide phosphatase myotubularin, are responsible for the X-linked centronuclear myopathy (XLCNM) or X-linked myotubular myopathy (XLMTM). The MTM1 gene was first identified in 1996 and its function as a PtdIns3P and PtdIns(,5)P2 phosphatase was discovered in 2000. In recent years, very important progress has been made to set up good models to study MTM1 and the XLCNM disease such as knockout or knockin mice, the Labrador Retriever dog, the zebrafish and the yeast Saccharomyces cerevisiae. These helped to better understand the cellular function of MTM1 and of its four conserved domains: PH-GRAM (Pleckstrin Homology-Glucosyltransferase, Rab-like GTPase Activator and Myotubularin), RID (Rac1-Induced recruitment Domain), PTP/DSP (Protein Tyrosine Phosphatase/Dual-Specificity Phosphatase) and SID (SET-protein Interaction Domain).
    [Show full text]
  • MTMR3 Is Upregulated in Patients with Breast Cancer and Regulates Proliferation, Cell Cycle Progression and Autophagy in Breast Cancer Cells
    ONCOLOGY REPORTS 42: 1915-1923, 2019 MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells ZHAN WANG1*, MIN ZHANG1*, RONG SHAN1, YU-JIE WANG1, JUAN CHEN2, JUAN HUANG3, LUN-QUAN SUN4 and WEI-BING ZHOU1 1Department of Oncology, 2Department of Pharmacy, 3Hunan Province Clinic Meditech Research Center for Breast Cancer, and 4Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China Received April 9, 2019; Accepted July 23, 2019 DOI: 10.3892/or.2019.7292 Abstract. As a member of the myotubularin family, myotu- Introduction bularin related protein 3 (MTMR3) has been demonstrated to participate in tumor development, including oral and colon Breast cancer is the second leading cause of cancer-related cancer. However, little is known about its functional roles in deaths in women, and the incidence of breast is estimated breast cancer. In the present study, the expression of MTMR3 in to increase by ~0.5% annually (1,2). Despite enormous breast cancer was evaluated by immunohistochemical staining progress on breast cancer therapy, 20% of patients eventu- of tumor tissues from 172 patients. Online data was then ally die of their disease (3,4). Multiple studies have revealed used for survival analysis from the PROGgeneV2 database. that breast cancer is a heterogeneous and complex disease, In vitro, MTMR3 expression was silenced in MDA-MB-231 whose pathophysiology cannot be explained by one or several cells via lentiviral shRNA transduction. MTT, colony forma- mechanisms (5). A number of reliable biological markers have tion and flow cytometry assays were performed in the control been found to predict the risk of recurrence and metastasis and MTMR3-silenced cells to evaluate the cell growth, of breast cancer.
    [Show full text]
  • MTMR3 Risk Allele Enhances Innate Receptor-Induced Signaling and Cytokines by Decreasing Autophagy and Increasing Caspase-1 Activation
    MTMR3 risk allele enhances innate receptor-induced signaling and cytokines by decreasing autophagy and increasing caspase-1 activation Amit Lahiri, Matija Hedl, and Clara Abraham1 Department of Medicine, Yale University, New Haven, CT 06511 Edited by David Artis, Weill Cornell Medical College, New York, NY, and accepted by the Editorial Board July 10, 2015 (received for review January 27, 2015) Inflammatory bowel disease (IBD) is characterized by dysregulated primary human cells, where responses can be dramatically different host:microbial interactions and cytokine production. Host pattern (8), has not been examined. Given the importance of PRR regu- recognition receptors (PRRs) are critical in regulating these interactions. lation in intestinal tissues and the ability of autophagy to modulate Multiple genetic loci are associated with IBD, but altered functions for PRR-initiated outcomes, we hypothesized that MTMR3 would most, including in the rs713875 MTMR3/HORMAD2/LIF/OSM region, are regulate PRR-induced autophagy and thereby PRR-induced sig- unknown. We identified a previously undefined role for myotubularin- naling and cytokine secretion. We further hypothesized that the related protein 3 (MTMR3) in amplifying PRR-induced cytokine secre- IBD-associated polymorphisms in the MTMR3/HORMAD2/LIF/ tion in human macrophages and defined MTMR3-initiated mechanisms OSM region would modulate these outcomes. contributing to this amplification. MTMR3 decreased PRR-induced In this study, we identified a role for MTMR3 in PRR-initiated phosphatidylinositol 3-phosphate (PtdIns3P) and autophagy levels, responses in primary human macrophages. Upon PRR stimulation, β thereby increasing PRR-induced caspase-1 activation, autocrine IL-1 MTMR3 decreased PtdIns3P levels and autophagy, which in turn κ secretion, NF B signaling, and, ultimately, overall cytokine secretion.
    [Show full text]
  • Protein Family Review
    http://genomebiology.com/2002/3/7/reviews/3009.1 Protein family review MAP kinase phosphatases comment Aspasia Theodosiou* and Alan Ashworth Addresses: *Biomedical Sciences Research Centre Alexander leming, PO Box 74145, Varkiza 166-02, Athens, Greece. The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, ulham Road, London SW3 6JB, UK. Correspondence: Alan Ashworth. E-mail: [email protected] Published: 26 June 2002 reviews Genome Biology 2002, 3(7):reviews3009.1–3009.10 The electronic version of this article is the complete one and can be found online at http://genomebiology.com/2002/3/7/reviews/3009 © BioMed Central Ltd (Print ISSN 1465-6906; Online ISSN 1465-6914) Summary reports Mitogen-activated protein MAP kinases are key signal-transducing enzymes that are activated by a wide range of extracellular stimuli. They are responsible for the induction of a number of cellular responses, such as changes in gene expression, proliferation, differentiation, cell cycle arrest and apoptosis. Although regulation of MAP kinases by a phosphorylation cascade has long been recognized as significant, their inactivation through the action of specific phosphatases has been less studied. An emerging family of structurally distinct dual-specificity serine, threonine and deposited research tyrosine phosphatases that act on MAP kinases consists of ten members in mammals, and members have been found in animals, plants and yeast. Three subgroups have been identified that differ in exon structure, sequence and substrate specificity. The mitogen-activated protein (MAP) kinases are evolution- phosphatases (DSPs) have been recognized as key players ary conserved enzymes that play an important role in for inactivating different MAP kinase isoforms; this class of refereed research orchestrating a variety of cellular processes, including prolif- phosphatases has been designated MAP kinase phos- eration, differentiation and apoptosis [1,2].
    [Show full text]
  • Live-Cell Imaging Rnai Screen Identifies PP2A–B55α and Importin-Β1 As Key Mitotic Exit Regulators in Human Cells
    LETTERS Live-cell imaging RNAi screen identifies PP2A–B55α and importin-β1 as key mitotic exit regulators in human cells Michael H. A. Schmitz1,2,3, Michael Held1,2, Veerle Janssens4, James R. A. Hutchins5, Otto Hudecz6, Elitsa Ivanova4, Jozef Goris4, Laura Trinkle-Mulcahy7, Angus I. Lamond8, Ina Poser9, Anthony A. Hyman9, Karl Mechtler5,6, Jan-Michael Peters5 and Daniel W. Gerlich1,2,10 When vertebrate cells exit mitosis various cellular structures can contribute to Cdk1 substrate dephosphorylation during vertebrate are re-organized to build functional interphase cells1. This mitotic exit, whereas Ca2+-triggered mitotic exit in cytostatic-factor- depends on Cdk1 (cyclin dependent kinase 1) inactivation arrested egg extracts depends on calcineurin12,13. Early genetic studies in and subsequent dephosphorylation of its substrates2–4. Drosophila melanogaster 14,15 and Aspergillus nidulans16 reported defects Members of the protein phosphatase 1 and 2A (PP1 and in late mitosis of PP1 and PP2A mutants. However, the assays used in PP2A) families can dephosphorylate Cdk1 substrates in these studies were not specific for mitotic exit because they scored pro- biochemical extracts during mitotic exit5,6, but how this relates metaphase arrest or anaphase chromosome bridges, which can result to postmitotic reassembly of interphase structures in intact from defects in early mitosis. cells is not known. Here, we use a live-cell imaging assay and Intracellular targeting of Ser/Thr phosphatase complexes to specific RNAi knockdown to screen a genome-wide library of protein substrates is mediated by a diverse range of regulatory and targeting phosphatases for mitotic exit functions in human cells. We subunits that associate with a small group of catalytic subunits3,4,17.
    [Show full text]
  • Expression Profile of Tyrosine Phosphatases in HER2 Breast
    Cellular Oncology 32 (2010) 361–372 361 DOI 10.3233/CLO-2010-0520 IOS Press Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors Maria Antonietta Lucci a, Rosaria Orlandi b, Tiziana Triulzi b, Elda Tagliabue b, Andrea Balsari c and Emma Villa-Moruzzi a,∗ a Department of Experimental Pathology, University of Pisa, Pisa, Italy b Molecular Biology Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy c Department of Human Morphology and Biomedical Sciences, University of Milan, Milan, Italy Abstract. Background: HER2-overexpression promotes malignancy by modulating signalling molecules, which include PTPs/DSPs (protein tyrosine and dual-specificity phosphatases). Our aim was to identify PTPs/DSPs displaying HER2-associated expression alterations. Methods: HER2 activity was modulated in MDA-MB-453 cells and PTPs/DSPs expression was analysed with a DNA oligoar- ray, by RT-PCR and immunoblotting. Two public breast tumor datasets were analysed to identify PTPs/DSPs differentially ex- pressed in HER2-positive tumors. Results: In cells (1) HER2-inhibition up-regulated 4 PTPs (PTPRA, PTPRK, PTPN11, PTPN18) and 11 DSPs (7 MKPs [MAP Kinase Phosphatases], 2 PTP4, 2 MTMRs [Myotubularin related phosphatases]) and down-regulated 7 DSPs (2 MKPs, 2 MTMRs, CDKN3, PTEN, CDC25C); (2) HER2-activation with EGF affected 10 DSPs (5 MKPs, 2 MTMRs, PTP4A1, CDKN3, CDC25B) and PTPN13; 8 DSPs were found in both groups. Furthermore, 7 PTPs/DSPs displayed also altered protein level. Analysis of 2 breast cancer datasets identified 6 differentially expressed DSPs: DUSP6, strongly up-regulated in both datasets; DUSP10 and CDC25B, up-regulated; PTP4A2, CDC14A and MTMR11 down-regulated in one dataset.
    [Show full text]
  • Phosphatases Page 1
    Phosphatases esiRNA ID Gene Name Gene Description Ensembl ID HU-05948-1 ACP1 acid phosphatase 1, soluble ENSG00000143727 HU-01870-1 ACP2 acid phosphatase 2, lysosomal ENSG00000134575 HU-05292-1 ACP5 acid phosphatase 5, tartrate resistant ENSG00000102575 HU-02655-1 ACP6 acid phosphatase 6, lysophosphatidic ENSG00000162836 HU-13465-1 ACPL2 acid phosphatase-like 2 ENSG00000155893 HU-06716-1 ACPP acid phosphatase, prostate ENSG00000014257 HU-15218-1 ACPT acid phosphatase, testicular ENSG00000142513 HU-09496-1 ACYP1 acylphosphatase 1, erythrocyte (common) type ENSG00000119640 HU-04746-1 ALPL alkaline phosphatase, liver ENSG00000162551 HU-14729-1 ALPP alkaline phosphatase, placental ENSG00000163283 HU-14729-1 ALPP alkaline phosphatase, placental ENSG00000163283 HU-14729-1 ALPPL2 alkaline phosphatase, placental-like 2 ENSG00000163286 HU-07767-1 BPGM 2,3-bisphosphoglycerate mutase ENSG00000172331 HU-06476-1 BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 ENSG00000162813 HU-09086-1 CANT1 calcium activated nucleotidase 1 ENSG00000171302 HU-03115-1 CCDC155 coiled-coil domain containing 155 ENSG00000161609 HU-09022-1 CDC14A CDC14 cell division cycle 14 homolog A (S. cerevisiae) ENSG00000079335 HU-11533-1 CDC14B CDC14 cell division cycle 14 homolog B (S. cerevisiae) ENSG00000081377 HU-06323-1 CDC25A cell division cycle 25 homolog A (S. pombe) ENSG00000164045 HU-07288-1 CDC25B cell division cycle 25 homolog B (S. pombe) ENSG00000101224 HU-06033-1 CDKN3 cyclin-dependent kinase inhibitor 3 ENSG00000100526 HU-02274-1 CTDSP1 CTD (carboxy-terminal domain,
    [Show full text]
  • Differential Phosphorylation of the Phosphoinositide 3-Phosphatase
    Research Article 1333 Differential phosphorylation of the phosphoinositide 3-phosphatase MTMR2 regulates its association with early endosomal subtypes Norah E. Franklin*, Christopher A. Bonham*, Besa Xhabija and Panayiotis O. Vacratsis` Department of Chemistry and Biochemistry, University of Windsor, Windsor, Ontario, N9B3P4, Canada *These authors contributed equally to this work `Author for correspondence ([email protected]) Accepted 2 January 2013 Journal of Cell Science 126, 1333–1344 ß 2013. Published by The Company of Biologists Ltd doi: 10.1242/jcs.113928 Summary Myotubularin-related 2 (MTMR2) is a 3-phosphoinositide lipid phosphatase with specificity towards the D-3 position of phosphoinositol 3-phosphate [PI(3)P] and phosphoinositol 3,5-bisphosphate lipids enriched on endosomal structures. Recently, we have shown that phosphorylation of MTMR2 on Ser58 is responsible for its cytoplasmic sequestration and that a phosphorylation-deficient variant (S58A) targets MTMR2 to Rab5-positive endosomes resulting in PI(3)P depletion and an increase in endosomal signaling, including a significant increase in ERK1/2 activation. Using in vitro kinase assays, cellular MAPK inhibitors, siRNA knockdown and a phosphospecific-Ser58 antibody, we now provide evidence that ERK1/2 is the kinase responsible for phosphorylating MTMR2 at position Ser58, which suggests that the endosomal targeting of MTMR2 is regulated through an ERK1/2 negative feedback mechanism. Surprisingly, treatment with multiple MAPK inhibitors resulted in a MTMR2 localization shift from Rab5-positive endosomes to the more proximal APPL1-positive endosomes. This MTMR2 localization shift was recapitulated when a double phosphorylation-deficient mutant (MTMR2 S58A/S631A) was characterized. Moreover, expression of this double phosphorylation-deficient MTMR2 variant led to a more sustained and pronounced increase in ERK1/2 activation compared with MTMR2 S58A.
    [Show full text]
  • Analysis of Phosphoinositide Binding Domain Properties Within the Myotubularin-Related Protein MTMR3
    Research Article 2005 Analysis of phosphoinositide binding domain properties within the myotubularin-related protein MTMR3 Óscar Lorenzo, Sylvie Urbé and Michael J. Clague* Physiological Laboratory, University of Liverpool, Crown Street, Liverpool, L69 3BX, UK *Author for correspondence (e-mail: [email protected]) Accepted 11 February 2005 Journal of Cell Science 118, 2005-2012 Published by The Company of Biologists 2005 doi:10.1242/jcs.02325 Summary The myotubularins are a large family of phosphoinositide- lipids, of which the allosteric regulator PtdIns5P is the specific phosphatases with substrate specificity for preferred partner. Consequently, generation of PtdIns5P PtdIns3P and PtdIns(3,5)P2. In addition to an N-terminal at the plasma membrane by ectopic expression of the PH-GRAM (PH-G) domain and a signature catalytic bacterial phosphatase IpgD leads to a translocation of domain shared with other family members, MTMR3 MTMR3 that requires the PH-G domain. Deletion of the contains a C-terminal FYVE domain. We show that the PH-G domain leads to loss of activity of MTMR3 in vitro, FYVE domain of MTMR3 is atypical in that it neither and surprisingly, when combined with an active site confers endosomal localisation nor binds to the lipid mutation, accumulates the protein on the Golgi complex. PtdIns3P. Furthermore the FYVE domain is not required for in vitro enzyme activity of MTMR3. In contrast, the Key words: Myotubularin, PH domain, FYVE domain, PH-GRAM domain is able to bind to phosphoinositide Phosphoinositides, Phosphatase, Golgi Introduction amongst the PH domain family is observed (Dowler et al., The myotubularins are a family of phosphoinositide 3- 2000).
    [Show full text]
  • Integrin-Linked Kinase Controls Renal Branching Morphogenesis Via Dual Specificity Phosphatase 8
    BASIC RESEARCH www.jasn.org Integrin-linked Kinase Controls Renal Branching Morphogenesis via Dual Specificity Phosphatase 8 †‡ Joanna Smeeton,* Priya Dhir,* Di Hu,* Meghan M. Feeney,* Lin Chen,* and † Norman D. Rosenblum* § *Program in Developmental and Stem Cell Biology, and §Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada; and †Departments of Paediatrics, and ‡Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada ABSTRACT Integrin-linked kinase (ILK) is an intracellular scaffold protein with critical cell-specific functions in the embryonic and mature mammalian kidney. Previously, we demonstrated a requirement for Ilk during ureteric branching and cell cycle regulation in collecting duct cells in vivo. Although in vitro data indicate that ILK controls p38 mitogen-activated protein kinase (p38MAPK) activity, the contribution of ILK- p38MAPK signaling to branching morphogenesis in vivo is not defined. Here, we identified genes that are regulated by Ilk in ureteric cells using a whole-genome expression analysis of whole-kidney mRNA in mice with Ilk deficiency in the ureteric cell lineage. Six genes with expression in ureteric tip cells, including Wnt11, were downregulated, whereas the expression of dual-specificity phosphatase 8 (DUSP8) was upregulated. Phosphorylation of p38MAPK was decreased in kidney tissue with Ilk deficiency, but no significant decrease in the phosphorylation of other intracellular effectors previously shown to control renal morphogenesis was observed. Pharmacologic inhibition of p38MAPK activity in murine inner med- ullary collecting duct 3 (mIMCD3) cells decreased expression of Wnt11, Krt23,andSlo4c1.DUSP8over- expression in mIMCD3 cells significantly inhibited p38MAPK activation and the expression of Wnt11 and Slo4c1. Adenovirus-mediated overexpression of DUSP8 in cultured embryonic murine kidneys decreased ureteric branching and p38MAPK activation.
    [Show full text]